Note: this report is being filed on an international product, list 07p60-74, that has a similar product distributed in the us, list number 07p60-21/-31.Section a1 - patient identifier complete entry = (b)(6) section e1 - phone number complete entry = (b)(6) all available patient information was included.Additional patient details are not available. the complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in house testing of a retained reagent kit.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.Ticket search by lot indicates the reagent lot is performing as expected for this product.A review of tracking and trending did not identify any trends for the issue for the product.Device history record review for lot 49616be01 did not identify any non-conformances or deviations with the complaint lot.In-house testing of a retained reagent kit of the complaint lot was performed.All specifications were met, and no false non-reactive results were obtained, indicating that the lot generates the expected results.(note: lot 49616be01 is a china specific lot and is identical to lot 49616be00).Both contain the same bulk material and are identical except the labeling of the outer package).Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency with the alinity i syphilis tp reagent lot 49616be01, was identified.
|
The customer observed false non-reactive alinity i syphilis tp result for a 66-year-old male patient sample.The following data was provided (reference range <1.0 s/co is nonreactive): 19sep2023 sample id (b)(6) after high-speed centrifugation of the sample, retest result with lot number 49616be01= 0.61 s/co; initial result on another alinity with lot number 50281be01 = 0.57 s/co wantai platform initial result = 6.0 s/co, repeat = 6.4 s/co (reference range >1.0 s/co is positive), colloidal gold = positive tppa = weak positive, trust = negative.Sample sent to another hospital and ran on chemclin luminescence platform.Result = positive historical result in december 2022 = 0.51 s/co no impact to patient management was reported.
|